REPORT ID 14155

United States Gastrointestinal Market Report 2019

Publish Date
2019
Pages
112
Format
Electronic (PDF)

In this report, the United States Gastrointestinal market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Gastrointestinal in these regions, from   2019 to 2025 (forecast).

United States Gastrointestinal market competition by top manufacturers/players, with Gastrointestinal sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZenec
    Sanofi
    Bayer
    Pfizer
    GlaxoSmithKline
    Teva
    Zeria?Tillotts?
    Perrigo
    Boehringer Ingelheim
    Purdue Pharma
    C.B. Fleet
    Abbott
    Jiangzhong
    Xian-Janssen

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Prescription Gastrointestinal Drug
    OTC Gastrointestinal Drug
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Gastrointestinal for each application, including
    Inflammatory Bowel Disease
    Ulcerative Colitis
    Irritable Bowel Syndrome Disease
    Crohn's Disease
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Gastrointestinal Market  Report 2019
1 Gastrointestinal Overview
    1.1 Product Overview and Scope of Gastrointestinal
    1.2 Classification of Gastrointestinal by Product Category
        1.2.1 United States Gastrointestinal Market Size (Sales Volume) Comparison by Type ( 2014-2024)
        1.2.2 United States Gastrointestinal Market Size (Sales Volume) Market Share by Type (Product Category)  in 2018
        1.2.3 Prescription Gastrointestinal Drug
        1.2.4 OTC Gastrointestinal Drug
    1.3 United States Gastrointestinal Market by Application/End Users
        1.3.1 United States Gastrointestinal Market Size (Consumption) and Market Share Comparison by Application ( 2014-2024)
        1.3.2 Inflammatory Bowel Disease
        1.3.3 Ulcerative Colitis
        1.3.4 Irritable Bowel Syndrome Disease
        1.3.5 Crohn's Disease
        1.3.6 Other
    1.4 United States Gastrointestinal Market by Region
        1.4.1 United States Gastrointestinal Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 The West Gastrointestinal Status and Prospect ( 2014-2024)
        1.4.3 Southwest Gastrointestinal Status and Prospect ( 2014-2024)
        1.4.4 The Middle Atlantic Gastrointestinal Status and Prospect ( 2014-2024)
        1.4.5 New England Gastrointestinal Status and Prospect ( 2014-2024)
        1.4.6 The South Gastrointestinal Status and Prospect ( 2014-2024)
        1.4.7 The Midwest Gastrointestinal Status and Prospect ( 2014-2024)
    1.5 United States Market Size (Value and Volume) of Gastrointestinal ( 2014-2024)
        1.5.1 United States Gastrointestinal Sales and Growth Rate ( 2014-2024)
        1.5.2 United States Gastrointestinal Revenue and Growth Rate ( 2014-2024)

2 United States Gastrointestinal Market Competition by Players/Suppliers
    2.1 United States Gastrointestinal Sales and Market Share of Key Players/Suppliers ( 2014-2019)
    2.2 United States Gastrointestinal Revenue and Share by Players/Suppliers ( 2014-2019)
    2.3 United States Gastrointestinal Average Price by Players/Suppliers ( 2014-2019)
    2.4 United States Gastrointestinal Market Competitive Situation and Trends
        2.4.1 United States Gastrointestinal Market Concentration Rate
        2.4.2 United States Gastrointestinal Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Gastrointestinal Manufacturing Base Distribution, Sales Area, Product Type

3 United States Gastrointestinal Sales (Volume) and Revenue (Value) by Region ( 2014-2019)
    3.1 United States Gastrointestinal Sales and Market Share by Region ( 2014-2019)
    3.2 United States Gastrointestinal Revenue and Market Share by Region ( 2014-2019)
    3.3 United States Gastrointestinal Price by Region ( 2014-2019)

4 United States Gastrointestinal Sales (Volume) and Revenue (Value) by Type (Product Category) ( 2014-2019)
    4.1 United States Gastrointestinal Sales and Market Share by Type (Product Category) ( 2014-2019)
    4.2 United States Gastrointestinal Revenue and Market Share by Type ( 2014-2019)
    4.3 United States Gastrointestinal Price by Type ( 2014-2019)
    4.4 United States Gastrointestinal Sales Growth Rate by Type ( 2014-2019)

5 United States Gastrointestinal Sales (Volume) by Application ( 2014-2019)
    5.1 United States Gastrointestinal Sales and Market Share by Application ( 2014-2019)
    5.2 United States Gastrointestinal Sales Growth Rate by Application ( 2014-2019)
    5.3 Market Drivers and Opportunities

6  United States Gastrointestinal Players/Suppliers Profiles and Sales Data
    6.1 AstraZenec
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Gastrointestinal Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AstraZenec Gastrointestinal Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi
        6.2.2 Gastrointestinal Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi Gastrointestinal Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Bayer
        6.3.2 Gastrointestinal Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Bayer Gastrointestinal Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.2 Gastrointestinal Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Gastrointestinal Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 GlaxoSmithKline
        6.5.2 Gastrointestinal Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 GlaxoSmithKline Gastrointestinal Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Teva
        6.6.2 Gastrointestinal Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Teva Gastrointestinal Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Zeria?Tillotts?
        6.7.2 Gastrointestinal Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Zeria?Tillotts? Gastrointestinal Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 Perrigo
        6.8.2 Gastrointestinal Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Perrigo Gastrointestinal Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Boehringer Ingelheim
        6.9.2 Gastrointestinal Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Boehringer Ingelheim Gastrointestinal Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Purdue Pharma
        6.10.2 Gastrointestinal Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Purdue Pharma Gastrointestinal Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 C.B. Fleet
    6.12 Abbott
    6.13 Jiangzhong
    6.14 Xian-Janssen

7 Gastrointestinal Manufacturing Cost Analysis
    7.1 Gastrointestinal Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Gastrointestinal

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Gastrointestinal Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Gastrointestinal Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Gastrointestinal Market Size (Value and Volume) Forecast ( 2019-2025)
    11.1 United States Gastrointestinal Sales Volume, Revenue Forecast ( 2019-2025)
    11.2 United States Gastrointestinal Sales Volume Forecast by Type ( 2019-2025)
    11.3 United States Gastrointestinal Sales Volume Forecast by Application ( 2019-2025)
    11.4 United States Gastrointestinal Sales Volume Forecast by Region ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer